Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.   - The regeneration process requires the activation ...

The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...

CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

Northwestern Medicine scientists have discovered new details about how the human genome produces instructions for creating ...

The Government of Canada is making a major push into genomics, investing $175.1 million to turn cutting-edge research into real-world breakthroughs in healthcare, agriculture, and clean technology.

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraise <li /> Prene ...

Humanity Protocol is partnering with genomics company Prenetics, to collaborate on blockchain-based identity verification and ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...